Theratechnologies Inc T.TH

Follow this thought with more..

[scarlet1967]

Attendance in conferences, don't let the excitement fade away. I have a feeling that the company won't release oncology trial specific information until the end of part1 of phase1 even so they might had/have that information.
They want to wait for DLT and possibly MTD to be confirmed by more cohorts and I don't buy the notion they won't get updated by cancer centre/centres. So we have a little time vacuum between now and late summer. Unless they have some NASH news they should get out there and keep promoting. This webinar didn't address the commercial side of the program despite many asked that question. Now prepare a retail
oriented pitch and attend retail platforms. Today over 280k shares were traded in Nasdaq, one of the highest daily volumes in weeks, the short volume spiked to over 26% which is over the average in the last few weeks too so THTX needs to stop this little shorting game every time they announce news by getting out there and convince the investors this is a good ROI in any time span as they will soon announce NASH protocol followed by oncology results followed by NASH trial..

[Wino115]

They need to give that webcast some legs, give that presentation to a few other conferences and keep pushing -I agree.  Getting  a thorough LSA report would go nicely with that pitch - one with more science and actual commercial aspects.  I also wonder about hitting a dose limiting toxicity. One slide shows there was essentially no free doxorubicin accumulating in the healthy

[palinc2000]

I believe that they did a lot of work behind the scene just to get institutional and other large investors to access todays web presentation. I think they have reached their goal of creating excitement and expectations . I am 99.9% sure that the ignition switch has been turned on ..... and slmost as sure that the 52 week high will be replaced by a new higher SP

[Bucknelly21]

I would like to think that's how it should be... however I bet red tomorrow just like usual 

[qwerty22]

I don't think they did a bad job in the fireside chats earlier in the year but today was very slick, very authorative and professional. Seems like they put a lot of preparation into getting this right, let's hope they allowed themselves to be coached to be better messengers, if they did then it showed thru. We are still weighed down by the last few years but I think anybody coming to

[scarlet1967]

That's very nice problem to have, I guess if no DLT after 6th cycle(no DLT in the 40 patients) in phase1 and MTD is much higher than therapeutic dosage for Docetaxel alone then they are free to use any dosage above the therapeutic level, they might not want to be too close to MTD as less adverse effects for patients. But that would be the ultimate success for the drug, probably not